Non-alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 28, Issue -, Pages 68-76
Publisher
Wiley
Online
2013-07-16
DOI
10.1111/jgh.12212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology and Natural History of Patients with NAFLD
- (2013) Neeraj Bhala et al. CURRENT PHARMACEUTICAL DESIGN
- Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents
- (2013) Maximilian Hatting et al. HEPATOLOGY
- Incretin hormones and the satiation signal
- (2013) J J Holst INTERNATIONAL JOURNAL OF OBESITY
- NAFLD in Asia—as common and important as in the West
- (2013) Geoffrey C. Farrell et al. Nature Reviews Gastroenterology & Hepatology
- Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
- (2012) James L. Trevaskis et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
- (2012) Danielle A.A. Hollman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase
- (2012) Manju Kumari et al. Cell Metabolism
- Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
- (2012) Donna L. White et al. Clinical Gastroenterology and Hepatology
- Adenosine A2areceptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats
- (2012) Chiara Imarisio et al. CLINICAL SCIENCE
- Can Nash Be Diagnosed, Graded, and Staged Noninvasively?
- (2012) Garfield A. Grandison et al. Clinics in Liver Disease
- Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
- (2012) Luciano Adorini et al. DRUG DISCOVERY TODAY
- Circulating Microparticles as Disease-Specific Biomarkers of Severity of Inflammation in Patients With Hepatitis C or Nonalcoholic Steatohepatitis
- (2012) Miroslaw Kornek et al. GASTROENTEROLOGY
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
- (2012) Anne Vrieze et al. GASTROENTEROLOGY
- Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease
- (2012) Carlos Jose Pirola et al. GUT
- Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice
- (2012) Dewei Ye et al. GUT
- Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes
- (2012) Manal F. Abdelmalek et al. HEPATOLOGY
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis
- (2012) Christopher Savard et al. HEPATOLOGY
- Excess cholesterol and fat in the diet: A dangerous liaison for energy expenditure and the liver
- (2012) Brent A. Neuschwander-Tetri et al. HEPATOLOGY
- Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease
- (2012) Ciaran E. Fealy et al. JOURNAL OF APPLIED PHYSIOLOGY
- Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
- (2012) John Zhong Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
- (2012) Jiayun Shen et al. JOURNAL OF HEPATOLOGY
- Lactobacillus casei Shirota protects from fructose-induced liver steatosis: A mouse model
- (2012) Sabine Wagnerberger et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Dietary trans-Fatty Acid Induced NASH is Normalized Following Loss of trans-Fatty Acids from Hepatic Lipid Pools
- (2012) Brent A. Neuschwander-Tetri et al. LIPIDS
- Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
- (2012) Zobair M. Younossi et al. MEDICINE
- Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
- (2012) Matthias Kern et al. PLoS One
- VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation
- (2012) Andrea Mencarelli et al. PLoS One
- PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function?
- (2012) Céline Dubuquoy et al. Clinics and Research in Hepatology and Gastroenterology
- Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet
- (2011) Jamie E. Mells et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Exercise, Appetite and Appetite-Regulating Hormones: Implications for Food Intake and Weight Control
- (2011) David Stensel ANNALS OF NUTRITION AND METABOLISM
- Nonalcoholic steatohepatitis
- (2011) Jörn M. Schattenberg et al. CURRENT OPINION IN LIPIDOLOGY
- Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
- (2011) B. Cariou et al. DIABETES CARE
- The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells
- (2011) L. Serrano-Marco et al. DIABETOLOGIA
- Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk
- (2011) David R Janero et al. Expert Opinion on Drug Discovery
- A High-Cholesterol Diet Exacerbates Liver Fibrosis in Mice via Accumulation of Free Cholesterol in Hepatic Stellate Cells
- (2011) Toshiaki Teratani et al. GASTROENTEROLOGY
- A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
- (2011) Vlad Ratziu et al. HEPATOLOGY
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
- (2011) Silvia Sookoian et al. HEPATOLOGY
- Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground
- (2011) Shivakumar Chitturi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Peroxisome proliferator-activated receptor-α agonist, Wy 14 643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis
- (2011) Claire Z Larter et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- No need for a large belly to have NASH
- (2011) Mariana Verdelho Machado et al. JOURNAL OF HEPATOLOGY
- Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms
- (2011) Anna Iacono et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance
- (2011) Jill A. Parnell et al. LIVER INTERNATIONAL
- GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy
- (2011) Shvetank Sharma et al. PLoS One
- The Effect of Lifestyle Changes in Non-Alcoholic Fatty Liver Disease
- (2010) Elena Centis et al. DIGESTIVE DISEASES
- Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism
- (2010) Sylvie Rabot et al. FASEB JOURNAL
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
- (2010) V. W.-S. Wong et al. GUT
- Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
- (2010) Manal F. Abdelmalek et al. HEPATOLOGY
- Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease
- (2010) Kausik Das et al. HEPATOLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Combination Therapy with Nateglinide and Vildagliptin Improves Postprandial Metabolic Derangements in Zucker Fatty Rats
- (2010) K. Miura et al. HORMONE AND METABOLIC RESEARCH
- Effects of Diet and Physical Activity Interventions on Weight Loss and Cardiometabolic Risk Factors in Severely Obese Adults
- (2010) Bret H. Goodpaster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adenosine: Tipping the balance towards hepatic steatosis and fibrosis
- (2010) Simon C. Robson et al. JOURNAL OF HEPATOLOGY
- Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis
- (2010) Quentin M. Anstee et al. JOURNAL OF HEPATOLOGY
- Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes
- (2010) Céline Dubuquoy et al. JOURNAL OF HEPATOLOGY
- Alterations in the Hippocampal Endocannabinoid System in Diet-Induced Obese Mice
- (2010) F. Massa et al. JOURNAL OF NEUROSCIENCE
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes and apoptosis: liver
- (2009) Jörn M. Schattenberg et al. APOPTOSIS
- Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology
- (2009) Norberto C Chavez-Tapia et al. BMC GASTROENTEROLOGY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
- (2009) Curtis K. Argo et al. Clinics in Liver Disease
- Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-Ay mice
- (2009) Kenji Katsuno et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice
- (2009) Astrid Spruss et al. HEPATOLOGY
- Adenosine signaling contributes to ethanol-induced fatty liver in mice
- (2009) Zhongsheng Peng et al. JOURNAL OF CLINICAL INVESTIGATION
- Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study
- (2009) Youming Li et al. JOURNAL OF HEPATOLOGY
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
- (2009) Curtis K. Argo et al. JOURNAL OF HEPATOLOGY
- Identification and Characterization of Metabolically Benign Obesity in Humans
- (2008) Norbert Stefan ARCHIVES OF INTERNAL MEDICINE
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
- Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
- (2008) Janus P. Ong et al. JOURNAL OF HEPATOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More